SynopsisThe global market for Plasma Therapy was valued at US$ 328 million in the year 2024 and is projected to reach a revised size of US$ 633 million by 2031, growing at a CAGR of 10.0% during the forecast period. Platelet-rich plasma (PRP) is a biological the.....
SynopsisThe global market for Budesonide Inhalation Aerosol was valued at US$ 252 million in the year 2024 and is projected to reach a revised size of US$ 405 million by 2031, growing at a CAGR of 7.0% during the forecast period. Budesonide is used to help preve.....
SynopsisThe global market for Personal Emergency Response Systems (PERS) was valued at US$ 8524 million in the year 2024 and is projected to reach a revised size of US$ 12830 million by 2031, growing at a CAGR of 6.1% during the forecast period. Personal emergen.....
SynopsisThe global market for O-arm 3D Imaging Navigator was valued at US$ 376 million in the year 2024 and is projected to reach a revised size of US$ 566 million by 2031, growing at a CAGR of 5.2% during the forecast period. The O-arm 3D Imaging Navigator is a.....
SynopsisThe global market for Clinical Trial was valued at US$ 55180 million in the year 2024 and is projected to reach a revised size of US$ 98770 million by 2031, growing at a CAGR of 8.8% during the forecast period. Clinical trials are experiments or observat.....
SynopsisThe global market for Dual-Antibody ADC was valued at US$ 522 million in the year 2024 and is projected to reach a revised size of US$ 736 million by 2031, growing at a CAGR of 5.7% during the forecast period. Dual-Antibody ADC is an innovative targeted .....
SynopsisThe global market for Analog X-ray Systems was valued at US$ 3282 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 1.5% during the forecast period. The Analog X-ray Systems industry can b.....
SynopsisThe global market for Ureteroscopy was valued at US$ 944 million in the year 2024 and is projected to reach a revised size of US$ 1246 million by 2031, growing at a CAGR of 4.1% during the forecast period. Ureteroscopy is a tubular instrument that enters.....
SynopsisThe global market for Albumin (as Excipient) was valued at US$ 4882 million in the year 2024 and is projected to reach a revised size of US$ 7346 million by 2031, growing at a CAGR of 6.1% during the forecast period. Albumin is a water-soluble globular p.....
SynopsisThe global market for Small Nucleic Acid Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period. Small Nucleic Acid D.....
